Dergiler / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 12

Life saving effect of early use of convalescent plasma in Covid-19 treatment

Sayfa
2242–2247
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We aimed to gather CP experiences up to date in COVID-19.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus, which is detected by the transmission from bat to person in Wuhan Province of China, has shown its effect all over the world in a very short time.
📊
Temel Bulgular & Veri:There is no treatment method proven effective in Coronavirus disease 2019 (COVID-19) pandemics.
💡
Sonuç & Katkı:We aimed to gather CP experiences up to date in COVID-19.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus, which is detected by the transmission from bat to person in Wuhan Province of China, has shown its effect all over the world in a very short time. There is no treatment method proven effective in Coronavirus disease 2019 (COVID-19) pandemics. The whole world is still working on it. Convalescent Plasma (CP) treatment is a passive antibody treatment that has been shown to be effective during periods of epidemic disease in history. CP treatment is interesting in the treatment of virus infection without vaccine or specific treatment, such as SARSCoV-2, which causes COVID-19. The mechanisms of action of CP include neutralizing the virus by direct binding, initiating virus elimination by complement activation, antibody-dependent cellular cytotoxicity and / or phagocytosis. Neutralizing antibodies are the most important mechanisms of action. The most important point in recovery is the inactivation of the virus and the prevention of viral replication. It was demonstrated for the first time that CP significantly reduced mortality in COVID-19 disease. Our results of CP treatment in COVID-19 patients have been published. We have shown that CP is effective and safe in COVID-19 disease. We aimed to gather CP experiences up to date in COVID-19.

🔖

Bu Makaleye Atıf Yap

KAYA, E., ERKURT, M. A., KUKU, I., SARICI, A., BERBER, I., BİÇİM, S., ÖZGÜL, M. (2022). Life saving effect of early use of convalescent plasma in Covid-19 treatment. Annals of Medical Research, Cilt: 28 - Sayı: 12, 2242–2247. https://ajindex.com/articles/445881

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Shahani L, Singh S, Khardori NM. Immunotherapy in clinical medicine: historical perspective and current status. Med Clin North Am 2012;96:421-31
  2. Roberts DJ, Miflin G, Estcourt L. Convalescent Plasma for COVID-19: back to the future. Transfus Med 2020;30
  3. O’Malley JJ, Hartman FW. Treatment of influenzal pneumonia with plasma of convalescent patients. JAMA 1919;72:34-7
  4. Korkmaz S, Medeni SS, Demirkan F, et al. The Turkish experience with therapeutic plasma exchange: A national survey. Transfus Apher Sci 2019;58:287-92
  5. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. J Heart Lung Transplant 2020;39:405
  6. Yigenoglu TN, Hacibekiroglu T, Berber I, et al. Convalescent plasma therapy in patients with COVID-19. J Clin Apher 2020;35:367-73
  7. Bloch EM, Shoham S, Casadevall A, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 2020;130:2757- 65
  8. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 2015;211:80-90
  9. Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 2020;323:1824-36
  10. Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci 2020;117:9490-6
  11. Gok S, Bahcecioglu OF, Arisoy S. Current Treatment Approaches for COVID-19’in Adults. J Lit Pharm Sci 2021
  12. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269-71
  13. Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 2020;323:1582-9
  14. Casadevall A, Pirofski L-A. The convalescent sera option for containing COVID-19. J Clin Invest 2020;130:1545-8
  15. Ahn JY, Sohn Y, Lee SH, et al. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci 2020;35:e149
  16. Zhang B, Liu S, Tan T, et al. Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection. Chest 2020;158:e9-e13
  17. Erkurt MA, Sarici A, Berber I, et al. Life-saving effect of convalescent plasm